Alnylam Pharmaceuticals
biopharmaceutical company
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Alnylam Pharmaceuticals’s social media accounts
Social
Web
2 external identifiers
Something wrong with this entry? Report it · How corrections work
Last updated · Handles last checked · How we check